Moyamoya disease in which pentazocine treatment caused cerebral infarction

Yoshinori Matsuoka1, Makoto Hashizume

  • 1Department of Emergency and Critical Care Center, Kyushu University Hospital, Fukuoka, Kyushu, Japan. yoshinori216@h2.dion.ne.jp

BMJ Case Reports
|July 14, 2012
PubMed

Insights

A young man

Area of Science:

  • Neurology
  • Vascular Neurology
  • Radiology

Background:

  • A 37-year-old male presented with perineal trauma and scrotal hematoma.
  • Patient experienced a decline in consciousness following pentazocine injections.

Observation:

  • Cerebral infarction was suspected due to CT findings of low signals in the left putamen, frontal lobe, and corticomedullary junction.
  • MR angiography revealed bilateral middle cerebral artery obstruction, leading to a diagnosis of moyamoya disease.

Findings:

  • Medical treatment with edaravone, argatroban, and heparin failed to restore blood flow in the middle cerebral arteries.
  • The patient suffered severe adverse effects.

Implications:

  • Cerebrovascular accident should be considered in young patients with altered consciousness, especially after drug administration affecting brain circulation.
  • Moyamoya disease diagnosis requires suspicion based on history and confirmation via MR angiography for timely intervention.
  • Early diagnosis and re-establishment of blood circulation are crucial for managing moyamoya disease and preventing severe outcomes.

Related Concept Videos

Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...